Skip to main content

CORRECTION article

Front. Immunol., 24 May 2022
Sec. Immunological Memory
Volume 13 - 2022 | https://doi.org/10.3389/fimmu.2022.929770

Corrigendum: Distinct Immune Response at 1 Year Post-COVID-19 According to Disease Severity

This article is a correction to:

  1. Distinct Immune Response at 1 Year Post-COVID-19 According to Disease Severity

    1. Read original article
Chang Kyung Kang&#x;Chang Kyung Kang1†Minji Kim,,&#x;Minji Kim2,3,4†Jisu Hong,,&#x;Jisu Hong2,4,5†Gwanghun Kim,,Gwanghun Kim2,3,4Soojin Lee,,Soojin Lee2,3,4Euijin ChangEuijin Chang1Pyoeng Gyun ChoePyoeng Gyun Choe1Nam Joong KimNam Joong Kim1Ik Soo KimIk Soo Kim6Jun-Young Seo,Jun-Young Seo7,8Daesub SongDaesub Song9Dong-Sup Lee,,,,Dong-Sup Lee2,3,4,10,11Hyun Mu Shin,,Hyun Mu Shin2,4,11Yong-Woo KimYong-Woo Kim11Chang-Han Lee,,,*&#x;Chang-Han Lee2,4,5,11*‡Wan Beom Park*&#x;Wan Beom Park1*‡Hang-Rae Kim,,,,*&#x;Hang-Rae Kim2,3,4,10,11*‡Myoung-don OhMyoung-don Oh1
  • 1Department of Internal Medicine, Seoul National University College of Medicine, Seoul, South Korea
  • 2Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul, South Korea
  • 3Department of Anatomy & Cell Biology, Seoul National University College of Medicine, Seoul, South Korea
  • 4BrainKorea21 (BK21) FOUR Biomedical Science Project, Seoul National University College of Medicine, Seoul, South Korea
  • 5Department of Pharmacology, Seoul National University College of Medicine, Seoul, South Korea
  • 6Department of Microbiology, School of Medicine, Gachon University, Incheon, South Korea
  • 7Severance Biomedical Science Institute, Yonsei University College of Medicine, Seoul, South Korea
  • 8BrainKorea21 (BK21) Project for Medical Science, Yonsei University College of Medicine, Seoul, South Korea
  • 9College of Pharmacy, Korea University, Sejong, South Korea
  • 10Medical Research Institute, Seoul National University College of Medicine, Seoul, South Korea
  • 11Wide River Institute of Immunology, Seoul National University, Hongcheon, South Korea

A Corrigendum on:
Distinct Immune Response at 1 Year Post-COVID-19 According to Disease Severity.

By Kang CK, Kim M, Hong J, Kim G, Lee S, Chang E, Choe PG, Kim NJ, Kim IS, Seo J-Y, Song D, Lee D-S, Shin HM, Kim Y-W, Lee C-H, Park WB, Kim H-R and Oh M-d (2022) Front. Immunol. 13:830433. doi: 10.3389/fimmu.2022.830433

In the original article, there was a mistake in Figure 3 as published. Figure 3D was repeatedly used instead of Figure 3F while reformatting the Figure 3 plots during the revision process. The corrected Figure 3 appears below.

FIGURE 3
www.frontiersin.org

Figure 3 Memory B-cell responses against SARS-CoV-2 according to the severity of illness. (A, C, E) Representative gating strategy for IgM+, IgA+, and IgG+ antigen-specific memory (CD27+ CD19+) B cells. (B, D, F) Frequencies of IgM+, IgA+, and IgG+ antigen-specific memory B cells according to the severity of illness and different antigens. Statistical analysis was performed using the Kruskal–Wallis rank-sum test with Dunn’s post hoc test in GraphPad Prism (n.s.: P > 0.05, *P < 0.05, **P < 0.01, ***P < 0.001).

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher’s Note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Keywords: SARS-CoV-2, antibody, phagocytosis, memory B cells, memory T cells

Citation: Kang CK, Kim M, Hong J, Kim G, Lee S, Chang E, Choe PG, Kim NJ, Kim IS, Seo J-Y, Song D, Lee D-S, Shin HM, Kim Y-W, Lee C-H, Park WB, Kim H-R and Oh M-d (2022) Corrigendum: Distinct Immune Response at 1 Year Post-COVID-19 According to Disease Severity. Front. Immunol. 13:929770. doi: 10.3389/fimmu.2022.929770

Received: 27 April 2022; Accepted: 02 May 2022;
Published: 24 May 2022.

Edited and reviewed by:

Michael Vajdy, EpitoGenesis, United States

Copyright © 2022 Kang, Kim, Hong, Kim, Lee, Chang, Choe, Kim, Kim, Seo, Song, Lee, Shin, Kim, Lee, Park, Kim and Oh. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Hang-Rae Kim, hangrae2@snu.ac.kr; Wan Beom Park, wbpark1@snu.ac.kr; Chang-Han Lee, chlee-antibody@snu.ac.kr

†These authors have contributed equally to this work

‡These authors have contributed equally to this work and share senior authorship

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.